Dermagraft

GUDID 00618474000015

Dermagraft is indicated for use in the treatment of full-thickness diabetic foot ulcers greater than six weeks duration, which extend through the dermis, but without tendon, muscle, joint capsule, or bone exposure. Dermagraft should be used in conjunction with standard wound care regimens and in patients that have adequate blood supply to the involved foot.

ORGANOGENESIS INC.

Skin regeneration template, human-/animal-derived

• Primary Device ID: 00618474000015
• NIH Device Record Key: 17ff0e99-7199-44d1-b844-9bde6d4ca4e7
• Commercial Distribution Status: In Commercial Distribution
• Brand Name: Dermagraft
• Version Model Number: 1
• Company DUNS: 152165817
• Company Name: ORGANOGENESIS INC.
• Device Count: 1
• DM Exempt: false
• Pre-market Exempt: false
• MRI Safety Status: Labeling does not contain MRI Safety Information
• Human Cell/Tissue Product: true
• Device Kit: false
• Device Combination Product: false
• Single Use: true
• Lot Batch: true
• Serial Number: false
• Manufacturing Date: false
• Expiration Date: true
• Donation Id Number: false
• Contains Natural Rubber Latex: false
• Labeled No Natural Rubber Latex: false
• RX Perscription: true
• OTC Over-The-Counter: false

Customer Support Contacts

• Phone: 1-877-337-6247
• Email: xxx@xxx.xx
• Phone: 1-877-337-6247
• Email: xxx@xxx.xx

Operating and Storage Conditions

• Storage Environment Temperature: Between -85 Degrees Celsius and -65 Degrees Celsius
• Storage Environment Temperature: Between -85 Degrees Celsius and -65 Degrees Celsius

Device Identifiers

Device Issuing Agency	Device ID
GS1	00618474000015 [Primary]

FDA Pre-market Approvals/Notifications & deNovo

• BP003600

FDA Product Code

• PFC: Cultured Human Cell Skin Dressing

Sterilization

• Steralize Prior To Use: false
• Device Is Sterile: false

Device Entry Metadata

• Public Version Status: Update
• Device Record Status: Published
• Public Version Number: 3
• Public Version Date: 2018-07-06
• Device Publish Date: 2014-09-24

Devices Manufactured by ORGANOGENESIS INC.

• 00618474000398 - PuraPly Micronized Wound Matrix (PuraPly MZ): 2023-05-09 PuraPly® Micronized Wound Matrix (PuraPly® MZ) consists of micronized porcine collagen intended for the management of wounds.
• 00618474000404 - PuraPly Micronized Wound Matrix (PuraPly MZ): 2023-05-09 PuraPly® Micronized Wound Matrix (PuraPly® MZ) consists of micronized porcine collagen intended for the management of wounds.
• 00618474000411 - PuraPly Micronized Wound Matrix (PuraPly MZ): 2023-05-09 PuraPly® Micronized Wound Matrix (PuraPly® MZ) consists of micronized porcine collagen intended for the management of wounds.
• 00618474000466 - PuraPly™ Antimicrobial XT Wound Matrix: 2021-12-09 PuraPly™ Antimicrobial XT Wound Matrix consists of a collagen sheet coated with 0.1% polyhexamethylenebiguanide hydrochloride
• 00618474000442 - PuraPly™ Antimicrobial Wound Matrix: 2021-04-14 uraPly™ Antimicrobial Wound Matrix (fenestrated) consists of a collagen sheet coated with polyhexamethylenebiguanide hydrochlo
• 00618474000459 - PuraPly™ Antimicrobial Wound Matrix: 2021-04-14 PuraPly™ Antimicrobial Wound Matrix consists of collagen sheets coated with polyhexamethylenebiguanide hydrochloride (PHMB) in
• 00618474000435 - PuraPly™ Antimicrobial Wound Matrix: 2020-10-12 PuraPly™ Antimicrobial Wound Matrix consists of collagen sheets coated with polyhexamethylenebiguanide hydrochloride (PHMB) in
• 00618474000206 - PuraForce™: 2020-05-06 PuraForce ™ tendon reinforcement matrix is a resorbable collagen based material intended for implantation to reinforce soft ti